Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria (clinicaltrials.gov) - Dec 14, 2020 - P1; N=32; Not yet recruiting; Sponsor: United BioPharma; Trial completion date: Jan 2023 ➔ Jan 2024; Trial primary completion date: Nov 2020 ➔ Nov 2022
Clinical • Trial completion date • Trial primary completion date • Dermatology • Urticaria
|